You are here

Home

Treatments

COVID, the flu or something else? 2024 symptoms and testing to know.

Fri, 2024-11-01 16:56 — mike kraft
Do I have COVID, the flu or something else? 2024 symptoms and testing to know. But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so important. CBS News

...

Determining your exact illness through testing also helps decide on the best course of treatment.

...

 

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Seasonal Flu
Symptoms
Treatments
Disease
Health
Medical Testing
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Hospital patient safety suffered under COVID pandemic pressures-- study

Fri, 2024-11-01 10:24 — mike kraft
Hospital patient safety suffered under COVID pandemic pressures, study shows The recommendations were made to shore up protection in vulnerable groups and add clarity for patients and healthcare providers. CIDRAP
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Data
Health
Hospitals
Medical Personnel
Pandemics
Public Health
Problem, Solution, SitRep, or ?: 
Analysis
Problem

Walking pneumonia is spiking U.S, especially among children; how to treat --CDC

Wed, 2024-10-30 10:07 — mike kraft
Walking pneumonia is spiking, especially in kids. Here's what to know If you or your kid has a cough that's been lingering, it could be a case of mycoplasma pneumonia. Cases are rising across the U.S. The good news — it's usually mild and easily treated. Here's how. NPR
Country / Region Tags: 
United States
General Topic Tags: 
Contagion
Symptoms
Treatments
Children
Government
Health
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID --study

Wed, 2024-10-30 09:51 — mike kraft
Paxlovid tied to fewer COVID-19 hospitalizations, reduced risk of long COVID Paxlovid was associated with a 61% lower risk of hospitalization. CIDRAP

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, is tied to a 61% reduction in COVID-19 hospitalization and a 58% lower rate of long COVID.

Country / Region Tags: 
Global
Middle East
General Topic Tags: 
COVID-19
Treatments
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Research into why protective antibodies fade after COVID-19 vaccines --NIH

Wed, 2024-10-30 09:46 — mike kraft
Why protective antibodies fade after COVID-19 vaccines New findings could help explain why the immune protection generated by COVID-19 vaccines tends to decline over time. National Institutes of Health (NIH)
  • Researchers found that current COVID-19 vaccines fail to generate mature and durable antibody-producing cells in the bone marrow.
  • The findings could help explain why protection tends to decline over time.
  • Better understanding of long-term immune responses could lead to improved vaccines that provide enduring protection.
  • ...
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Capacity
Disease Prevention
Health
Mutations
Public Attitudes
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Long COVID symptoms: Study assesses 'symptom diary' of trial participants

Fri, 2024-10-18 10:19 — mike kraft
Search continues for treatment that reduces long COVID symptoms: Study assesses 'symptom diary' of trial participants The first randomized, placebo-controlled clinical trial evaluating the impact of therapeutic monoclonal antibodies on the risk of developing long COVID was led by researchers at Weill Cornell Medicine. ... Weill Cornell Medical College Medical Xpress
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Health
Medical Testing
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Hurricane suppply disruptions of IV fluid prompt Biden administration to invoke wartime powers to bolster recovery

Wed, 2024-10-16 09:50 — mike kraft
IV fluid supply disruptions prompt Biden administration to invoke wartime powers to bolster recovery | CNN Disruptions from Hurricane Helene exacerbated shortages of critical intravenous fluids in the United States, and now the Biden administration has invoked the wartime powers of the Defense Production Act in the latest move to help speed recovery efforts. Deidre McPhillips CNN

...

Country / Region Tags: 
United States
General Topic Tags: 
Treatments
Capacity
Government
Health
Hospitals
Policy
Public Health
Scarcity
Problem, Solution, SitRep, or ?: 
Situation Report

RSV: Can be deadly for older adults. Information about symptoms and the new vaccine

Mon, 2024-10-07 10:30 — mike kraft
RSV can be deadly—especially for older adults. Why aren’t more of them getting the new vaccine? About 6,000 to 10,000 people 65 and older die from RSV in the U.S. annually, the CDC says. Lindsey Leake Fortune

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
RSV
Symptoms
Treatments
Disease
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

WHO to call for urgent, high-level action to address global problem of antimicrobial resistance

Fri, 2024-09-20 17:39 — mike kraft
WHO at UNGA: Call for urgent, high-level action to address global scourge of antimicrobial resistance The World Health Organization (WHO) and partners will call on world leaders to address critical global health challenges, and invest in global public health, at meetings throughout the high-level week of the 79th session of the United Nations General Assembly (UNGA79), to be held in New York from 20 to 30 September 2024.
Country / Region Tags: 
Global
United Nations
General Topic Tags: 
Treatments
Disease
Disease Prevention
Government
Health
Public Health
Problem, Solution, SitRep, or ?: 
Problem
Situation Report

Common diabetes drug may lower rate of long COVID --study

Fri, 2024-09-20 10:36 — mike kraft
Common diabetes drug linked to lower rate of long COVID Metformin is the most common type 2 diabetes drug prescribed to millions of American each year, and a new study from researchers at the National Institutes of Health (NIH) published in Diabetes Care suggests the drug can lower the risk of developing long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), in diabetics. CIDRAP

...

Metformin lowers blood sugar and is most commonly prescribed as a first-line treatment for type 2 diabetes. The drug also is prescribed off-label for weight loss and other metabolic conditions.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Government
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Solutions

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.716 seconds.